Quantum BioPharma Set to Shine at Global Growth and Investment Conference
Quantum BioPharma is set to present at the Global Growth and Investment Conference, showcasing its innovative solutions and growth potential in the biopharmaceutical sector.
Copper Fox Metals Inc. is dedicated to developing Tier 1 copper projects in Canada and the USA. The company's portfolio includes advanced-stage projects such as the Van Dyke project in Arizona and the Eaglehead project in British Columbia. One of their most prominent ventures is the Schaft Creek project in British Columbia, managed through a joint venture with Teck Resources, where Copper Fox holds a 25% interest.
Copper Fox Metals Inc. experienced a significant change in its stock price this past week. The stock jumped from CAD 0.21 to CAD 0.42, representing an exact 100% appreciation in value. During the week, the stock reached a high of CAD 0.65 on Thursday, with a weekly trading volume of 14 million shares.
The recent spike in Copper Fox Metals' stock price can be attributed to several key factors:
Teck Resources, Copper Fox's partner in the Schaft Creek project, is expected to deliver significant updates soon. These updates are anticipated to cover several critical aspects of the project, including advancements in geological, metallurgical, and environmental studies. The 2024 Schaft Creek program, with a budget of CA$18.7 million, aims to transition the project from the Scoping to the Prefeasibility Study stage. Specific areas of focus include completing the metallurgical test work program, 4,500 meters of drilling in key technical areas, updates to the resource and geological models, and continued collaboration with the Tahltan Nation. These forthcoming developments are poised to enhance the project's economic viability and technical certainty, making it a highly anticipated event for stakeholders.
The global rise in copper prices has played a significant role in boosting investor confidence. As copper is a crucial component in various industries, including electronics and renewable energy, its demand has been on the rise, leading to higher prices.
The Joint Venture team at Schaft Creek is in the process of updating all economic data with current inputs and metal pricing. This includes a new assessment of the project's financial viability, which is likely to show improved metrics given the current market conditions. The last Preliminary Economic Assessment in 2021 already showed a substantial valuation increase over the 2013 Feasibility Study, with an after-tax NPV of US$842 million and an IRR of 12.9%.
Sources: Information has been sourced from Copper Fox Metals' official website and corporate presentations. Learn more here copperfoxmetals.com
Quantum BioPharma is set to present at the Global Growth and Investment Conference, showcasing its innovative solutions and growth potential in the biopharmaceutical sector.
Alamos Gold has established a new research chair to enhance the detection and treatment of gastrointestinal cancers, contributing $2 million to The Princess Margaret Cancer Foundation.
Elite Pharma sets sights on market growth with key product rollouts ahead.
We're just a bunch of guys mixing up market news with our own brand of banter, giving you the lowdown on stocks with a twist at Walk The Street Capital.